| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Research and development | $1.7M-78.6% | $8.1M-25.3% | $10.8M+5464.4% | $194K |
| General and administrative expenses | $3.7M-12.4% | $4.2M-12.4% | $4.8M-50.6% | $9.8M |
| Total operating expenses | $5.4M-55.8% | $12.3M-21.3% | $15.6M+56.3% | $10.0M |
| Loss from operations | -$5.4M+55.8% | -$12.3M+21.3% | -$15.6M-56.3% | -$10.0M |
| Interest income | $151K+123.6% | $67K+1089.6% | $6K+101.5% | -$384K |
| Total other income | $151K+123.6% | $67K+121.1% | -$319K+6.4% | -$341K |
| Loss before income taxes | -$5.3M+56.8% | -$12.2M+23.3% | -$16.0M-54.3% | -$10.3M |
| Net loss | -$5.3M+56.8% | -$12.2M+23.3% | -$16.0M-54.3% | -$10.3M |
| Basic net loss per share (in dollars per share) | -$0.28+74.8% | -$1.11+42.2% | -$1.92+8.6% | -$2.10 |
| Diluted net loss per share (in dollars per share) | -$0.28+74.8% | -$1.11+42.2% | -$1.92+8.6% | -$2.10 |
| Weighted average number of shares outstanding - basic (in shares) | 18.8M+69.6% | 11.1M+32.9% | 8.3M+69.1% | 4.9M |
| Weighted average number of shares outstanding - diluted (in shares) | 18.8M+69.6% | 11.1M+32.9% | 8.3M+69.1% | 4.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.